Effect of Initial Prednisone Dosing on Ocular Myasthenia Control at 1 Month

Update Item Information
Identifier 20200310_nanos_posters_224
Title Effect of Initial Prednisone Dosing on Ocular Myasthenia Control at 1 Month
Creator Yesha Shah, Amanda Henderson, Andrew Carey
Subject Neuro-ophth & Systemic Disease (eg. MS, MG, Thyroid), Myasthenia
Description Ocular myasthenia gravis (OMG) is an autoimmune condition responsive to corticosteroids. Experts recommend corticosteroids as first line immunosuppressive treatment (1); however, no guidelines exist for initial dosing. Prior retrospective reports have suggested initial doses of 40-80 mg daily (2) but also have demonstrated success at doses as low as 10 mg daily (3). The goal of this study is to determine whether initial prednisone dosing has any effect on symptoms control at 1 month.
Date 2020-03
Language eng
Format application/pdf
Source 2020 North American Neuro-Ophthalmology Society Annual Meeting
Relation is Part of NANOS Annual Meeting 2020: Poster Session II: Scientific Advancements
Collection Neuro-ophthalmology Virtual Education Library: NOVEL http://NOVEL.utah.edu
Publisher Spencer S. Eccles Health Sciences Library, University of Utah
Holding Institution North American Neuro-Ophthalmology Association. NANOS Executive Office 5841 Cedar Lake Road, Suite 204, Minneapolis, MN 55416
Rights Management Copyright 2020. For further information regarding the rights to this collection, please visit: https://NOVEL.utah.edu/about/copyright
ARK ark:/87278/s6mw7snr
Context URL The NANOS Annual Meeting Neuro-Ophthalmology Collection: https://novel.utah.edu/collection/NAM/toc/
Contributor Primary Yesha Shah
Contributor Secondary Amanda Henderson, Andrew Carey
Setname ehsl_novel_nam
ID 1542092
Reference URL https://collections.lib.utah.edu/ark:/87278/s6mw7snr
Back to Search Results